Artiva Biotherapeutics (ARTV) Depreciation & Amortization (CF) (2023 - 2026)
Artiva Biotherapeutics (ARTV) recorded Depreciation & Amortization (CF) of $692,000 in Q2 2026, up 8.0% from $641,000 a year earlier and up 3.9% from the prior quarter.
Powered by 
Analysis
Artiva Biotherapeutics (ARTV) Depreciation & Amortization (CF) (2023 - 2026) Analysis & Trends
On a TTM basis, Artiva Biotherapeutics' Depreciation & Amortization (CF) came in at $2.69 million as of Jun 30, 2026, up 7.0% year-over-year; for FY2025, it was $2.6 million, up 6.8% from FY2024.
- Across earlier years, Depreciation & Amortization (CF) came in at $2.43 million in FY2024 (+7.3%) and $2.27 million in FY2023.
- The Q2 2026 figure is the highest quarterly Depreciation & Amortization (CF) in data going back to Q2 2023.
- On a year-over-year basis, Depreciation & Amortization (CF) has increased for nine consecutive quarters, with growth averaging 7.2% over the last eight quarters.
- The year-over-year growth in Depreciation & Amortization (CF) has ranged between 3.4% (Q4 2024) and 20.6% (Q2 2024) over the last five years.
- Per Business Quant, the preceding three quarters came in at $666,000 (Q1 2026), $666,000 (Q4 2025) and $662,000 (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Dep. & Amort. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,230.11 Bn | 1,198.70 Bn | 19.71 Bn | 534.00 Mn |
| 2 | Johnson & Johnson | 644.39 Bn | 564.25 Bn | 17.30 Bn | 2.12 Bn |
| 3 | AbbVie | 503.52 Bn | 476.68 Bn | 12.70 Bn | 194.00 Mn |
| 4 | Merck | 363.29 Bn | 317.72 Bn | 12.21 Bn | 599.00 Mn |
| 5 | Novartis Ag | 298.23 Bn | 262.62 Bn | 11.24 Bn | - |
| 6 | Astrazeneca | 267.53 Bn | 241.29 Bn | 12.86 Bn | 1.93 Bn |
| 7 | Amgen | 241.80 Bn | 197.20 Bn | 7.24 Bn | 1.11 Bn |
| 8 | Gilead Sciences | 195.07 Bn | 169.19 Bn | 6.22 Bn | 98.00 Mn |
| 9 | Pfizer | 173.33 Bn | 120.28 Bn | 10.94 Bn | 1.62 Bn |
| 10 | Artiva Biotherapeutics | 244.36 Mn | -105.04 Mn | - | 692,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 692,000.00 |
| Mar 31, 2026 | 666,000.00 |
| Dec 31, 2025 | 666,000.00 |
| Sep 30, 2025 | 662,000.00 |
| Jun 30, 2025 | 641,000.00 |
| Mar 31, 2025 | 628,000.00 |
| Dec 31, 2024 | 614,000.00 |
| Sep 30, 2024 | 627,000.00 |
| Jun 30, 2024 | 603,000.00 |
| Mar 31, 2024 | 587,000.00 |
| Dec 31, 2023 | 594,000.00 |
| Sep 30, 2023 | 556,000.00 |
| Jun 30, 2023 | 500,000.00 |
API Access
Artiva Biotherapeutics Depreciation & Amortization (CF) API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=depreciation-and-amortization-cf&ticker=ARTV&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "depreciation-and-amortization-cf", "ticker": "ARTV", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=depreciation-and-amortization-cf&ticker=ARTV&period=max&api_key=YOUR_API_KEY");
const data = await res.json();